These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35401531)

  • 21. The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER.
    Hall BS; Hill K; McKenna M; Ogbechi J; High S; Willis AE; Simmonds RE
    PLoS Pathog; 2014 Apr; 10(4):e1004061. PubMed ID: 24699819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease.
    Sarfo FS; Phillips R; Wansbrough-Jones M; Simmonds RE
    Cell Microbiol; 2016 Jan; 18(1):17-29. PubMed ID: 26572803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease.
    Niang F; Sarfo FS; Frimpong M; Guenin-Macé L; Wansbrough-Jones M; Stinear T; Phillips RO; Demangel C
    Sci Rep; 2015 Dec; 5():17693. PubMed ID: 26634444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin.
    Coutanceau E; Marsollier L; Brosch R; Perret E; Goossens P; Tanguy M; Cole ST; Small PL; Demangel C
    Cell Microbiol; 2005 Aug; 7(8):1187-96. PubMed ID: 16008585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer.
    Hall BS; Hsieh LT; Sacre S; Simmonds RE
    Front Immunol; 2021; 12():788146. PubMed ID: 35154073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Mycobacterium species for the presence of a macrolide toxin, mycolactone.
    Daniel AK; Lee RE; Portaels F; Small PL
    Infect Immun; 2004 Jan; 72(1):123-32. PubMed ID: 14688089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.
    Silva MT; Portaels F; Pedrosa J
    Lancet Infect Dis; 2009 Nov; 9(11):699-710. PubMed ID: 19850228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease.
    Sarfo FS; Converse PJ; Almeida DV; Zhang J; Robinson C; Wansbrough-Jones M; Grosset JH
    PLoS Negl Trop Dis; 2013; 7(3):e2101. PubMed ID: 23516649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.
    Fraga AG; Cruz A; Martins TG; Torrado E; Saraiva M; Pereira DR; Meyers WM; Portaels F; Silva MT; Castro AG; Pedrosa J
    Infect Immun; 2011 Jan; 79(1):421-30. PubMed ID: 20974825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From Bacterial Toxin to Therapeutic Agent: The Unexpected Fate of Mycolactone.
    Ricci D; Demangel C
    Toxins (Basel); 2023 May; 15(6):. PubMed ID: 37368670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adhesion of the ulcerative pathogen Mycobacterium ulcerans to DACC-coated dressings.
    Geroult S; Phillips RO; Demangel C
    J Wound Care; 2014 Aug; 23(8):417-8, 422-4. PubMed ID: 25139600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of Mycolactone A/B in Mycobacterium ulcerans-Infected Human Tissue.
    Sarfo FS; Phillips RO; Rangers B; Mahrous EA; Lee RE; Tarelli E; Asiedu KB; Small PL; Wansbrough-Jones MH
    PLoS Negl Trop Dis; 2010 Jan; 4(1):e577. PubMed ID: 20052267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of mycolactone, the Mycobacterium ulcerans toxin, depends on nutrient source.
    Deshayes C; Angala SK; Marion E; Brandli I; Babonneau J; Preisser L; Eyangoh S; Delneste Y; Legras P; De Chastellier C; Stinear TP; Jackson M; Marsollier L
    PLoS Negl Trop Dis; 2013 Nov; 7(11):e2502. PubMed ID: 24244764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and Characterization of Extracellular Vesicles from Mycobacterium ulcerans Culture.
    Foulon M; Marion E; Marsollier L
    Methods Mol Biol; 2022; 2387():41-51. PubMed ID: 34643900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naturally occurring a loss of a giant plasmid from Mycobacterium ulcerans subsp. shinshuense makes it non-pathogenic.
    Nakanaga K; Ogura Y; Toyoda A; Yoshida M; Fukano H; Fujiwara N; Miyamoto Y; Nakata N; Kazumi Y; Maeda S; Ooka T; Goto M; Tanigawa K; Mitarai S; Suzuki K; Ishii N; Ato M; Hayashi T; Hoshino Y
    Sci Rep; 2018 May; 8(1):8218. PubMed ID: 29844323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of
    Foulon M; Pouchin A; Manry J; Khater F; Robbe-Saule M; Durand A; Esnault L; Delneste Y; Jeannin P; Saint-André JP; Croué A; Altare F; Abel L; Alcaïs A; Marion E
    Sci Adv; 2020 Feb; 6(9):eaax7781. PubMed ID: 32133396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycobacterium ulcerans infections cause progressive muscle atrophy and dysfunction, and mycolactone impairs satellite cell proliferation.
    Houngbédji GM; Bouchard P; Frenette J
    Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R724-32. PubMed ID: 21209381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone.
    Torrado E; Fraga AG; Logarinho E; Martins TG; Carmona JA; Gama JB; Carvalho MA; Proença F; Castro AG; Pedrosa J
    J Immunol; 2010 Jan; 184(2):947-55. PubMed ID: 20008288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative boronic acids in the detection of Mycolactone A/B using the thin layer chromatography (f-TLC) method for diagnosis of Buruli ulcer.
    Akolgo GA; Partridge BM; D Craggs T; Amewu RK
    BMC Infect Dis; 2023 Jul; 23(1):495. PubMed ID: 37501134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterium ulcerans cytotoxicity in an adipose cell model.
    Dobos KM; Small PL; Deslauriers M; Quinn FD; King CH
    Infect Immun; 2001 Nov; 69(11):7182-6. PubMed ID: 11598099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.